glp 1 mental health effects Transformation 2.0: The GLP-1 RAs as Psychiatric Medications? Exploring the Side Effects of

The SELECT trial, published in the New England Journal of Medicine in 2023, demonstrated that semaglutide significantly reduced major adverse cardiovascular events in patients with established cardiovascular disease and overweight or obesity, representing a landmark finding for GLP-1 receptor agonists in cardiovascular risk reduction

Fred Sattler at University of Southern California Keck School of Medicine

Work with our expert lifestyle coaches to develop healthy habits and build a sustainable foundation for long-term success

Semaglutide promotes weight loss by: Appetite suppression: By activating GLP-1 receptors in the brain, Semaglutide helps to reduce hunger and increase feelings of fullness, leading to decreased calorie intake